BGI & ACRG Team up to Accelerate Cancer Research in Asia

The two parties will work together to conduct genomic research on lung cancer and liver cancer, two of the most common cancers in Asia.

BGI, the world's largest genomics organization and Asia Cancer Research Group (ACRG), a not-for-profit organization established to accelerate research and ultimately improve treatment for patients affected with the most commonly-diagnosed cancers in Asia, jointly announced a new collaboration on cancer genomics research as part of ACRG's mission to generate a unique and best-in-class data source on cancers prevalent in Asia, and to accelerate research and development of improved treatments for those cancers by freely sharing the resulting data with the scientific community.

The two parties will work together to conduct genomic research on lung cancer and liver cancer, two of the most common cancers in Asia. BGI and ACRG will conduct the lung and liver cancer studies at the genomic level. ACRG will provide samples of lung and